Literature DB >> 9879999

Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation.

A Hengstermann1, N J Whitaker, D Zimmer, H Zentgraf, M Scheffner.   

Abstract

The growth suppressive properties of the tumor suppressor protein p53 are activated upon DNA damage. The activation of p53 is reflected in increased p53 levels which are, at least in part, the result of an extended half-life of the protein. Although this suggests that stabilization of p53 is an intrinsic feature of p53 activation, the mechanisms involved in p53 degradation and stabilization are poorly understood. Here we report on the identification of an internal deletion mutant of wild-type p53, termed delta62-96, which can be stably expressed in various cell lines. This deletion mutant has a turnover rate similar to wild-type p53 and its stability is upregulated by treatment with UV light. In cell lines that express endogenous mutant or no p53, however, delta62-96 appears to be stable, strongly indicating that these cell lines have lost the ability to degrade p53. Further characterization of delta62-96 by mutational analyses defines sequence and structural requirements for p53 degradation and indicates that none of the known p53 phosphorylation sites is essential with respect to p53 stability regulation upon UV-irradiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879999     DOI: 10.1038/sj.onc.1202282

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.

Authors:  J T Zilfou; W H Hoffman; M Sank; D L George; M Murphy
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

4.  Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.

Authors:  C Blattner; A Sparks; D Lane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.

Authors:  M K Lee; W M Tong; Z Q Wang; K Sabapathy
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

6.  Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53.

Authors:  Arnd Hengstermann; Michael A D'silva; Petric Kuballa; Karin Butz; Felix Hoppe-Seyler; Martin Scheffner
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.

Authors:  Simone Kühnle; Benedikt Mothes; Konstantin Matentzoglu; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

8.  HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

Authors:  Laëtitia K Linares; Arnd Hengstermann; Aaron Ciechanover; Stefan Müller; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

9.  p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK.

Authors:  Karen A Boehme; Roman Kulikov; Christine Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-27       Impact factor: 11.205

10.  Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta.

Authors:  LiKe Qu; Shirley Huang; Dionissios Baltzis; Ana-Maria Rivas-Estilla; Olivier Pluquet; Maria Hatzoglou; Costas Koumenis; Yoichi Taya; Akihiko Yoshimura; Antonis E Koromilas
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.